UCB4940
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UCB4940, covering 2015-08-20 to 2017-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis [Phase 2]